pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Apr 26·1 min read
save

Investment in UK biotechs shows early signs of recovery, report says

After a lull in mid-2025, investment in UK biotechs appears to be picking up, according to data from the UK trade group the BioIndustry Association. In the first quarter of 2026, total equity funding in ...

Apr 26, 2026·read at Endpoints ↗

April 26, 2026 07:01 PM EDT Financing In­vest­ment in UK biotechs shows ear­ly signs of re­cov­ery, re­port says Anna Brown News Reporter Af­ter a lull in mid-2025, in­vest­ment in UK biotechs ap­pears to be pick­ing up, ac­cord­ing to da­ta from the UK trade group the BioIn­dus­try As­so­ci­a­tion. … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

source

Reporting by Endpoints.

read at Endpoints ↗
82 words · retrieved Apr 27
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 3h agoMerck's top dealmaker signals more M&A as Keytruda's patent cliff nearsEndpoints
  • 6h agoNovartis' drug delivery deal with Alteogen; More worker cuts at CellaresEndpoints
  • 6h agoPfizer shares ADC rights with Medicus; RevMed updates lung cancer dataEndpoints
  • 7h agoAbbVie claims Phase 3 win for multiple myeloma drug etentamigEndpoints
  • 8h agoHealth tech investors are looking at bigger betsEndpoints